Scientific report 2023 of the Acute Leukemia Working Party (ALWP)

The activity of the ALWP continues to increase thanks to the great contribution of the ALWP members and collaborators and the continuous efforts of the ALWP staff. Study proposals are presented with relevant questions for investigating factors associated with patients outcomes. All these achievements are possible with the continuous and voluntary work of distinguished colleagues, and I thank all of them for it. 

One of the main topics of the ALWP is the data collection on next-generation sequencing (NGS) data and use of novel drugs, with the aim to improve the quality of the registry and the scientific output of the publications to the benefit of the patient's care.  

The number of transplants for patients with acute leukaemia is constantly growing, with increase in the HCT indications, as well the age of the patients and diseases. The role of age and donor kinship has been analysed in different transplant settings to implement the algorithm of donor selection for patients in need of HCT. 

I am very grateful for your tireless efforts in sending such complex data, which will definitely lead to the generation of new knowledge to further advance the management of acute leukaemia.

• 7th IPC Symposium Advances in Transplant and Cellular Immunotherapy in Older Patients - 23-25 June 2023 in Marseille, France